Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$3495
Buy Report Download FREE Resources

Published: April 08, 2026 Report Code: GDHC026MV-ST

Select Item

Analyze the global thyroid cancer therapeutics market with GlobalData’s competitive intelligence report covering epidemiology trends, pipeline analysis, clinical trials, pricing and reimbursement, marketed therapies, and future market opportunities. Explore thyroid cancer market forecasts, treatment landscape evolution, targeted therapy development, immunotherapy trends, late-stage pipeline assets, and commercial dynamics shaping the global thyroid cancer therapeutics industry. The report provides detailed insight into disease prevalence, mechanism of action analysis, clinical trial activity, strategic alliances, mergers and acquisitions, and competitive benchmarking across the thyroid cancer treatment ecosystem. Built on GlobalData’s Pharma Intelligence Center and supported by expert analyst insights, this report helps pharmaceutical companies, biotech firms, investors, and strategy teams identify growth opportunities, benchmark competitors, and support long-term commercial planning within the thyroid cancer therapeutics market.

Report Value Proposition – Why This Matters for You

The thyroid cancer therapeutics market continues to evolve as targeted therapies become increasingly integrated into standard treatment protocols for advanced disease management. In parallel, immunotherapies are emerging as promising experimental approaches for selected patient populations, while late-stage pipeline development continues to reshape the future competitive landscape.

This report helps you understand how epidemiology trends, treatment innovation, pipeline development, and strategic industry activity are shaping the global thyroid cancer therapeutics market. In addition, it provides detailed analysis across marketed products, clinical development pipelines, pricing and reimbursement frameworks, and competitive positioning.

The report also delivers comprehensive insight into clinical trials, mechanism of action trends, phase transition probabilities, deal activity, and commercial forecasts to support strategic planning, licensing decisions, competitive intelligence, and investment evaluation.

Key Insights in the Thyroid Cancer Therapeutics Market

  • China is projected to account for the highest number of diagnosed prevalent thyroid cancer cases in both 2024 and 2029.
  • Targeted therapies have become part of the standard care landscape for advanced thyroid cancer.
  • Immunotherapies are emerging as experimental treatment options for selected patients.
  • The thyroid cancer pipeline currently includes 119 molecules.
  • Eight pipeline assets are currently in Phase III development.
  • No products are currently in the pre-registration stage.
  • Over the past decade, 575 clinical trials have been conducted in thyroid cancer.
  • 2023 and 2022 recorded the highest number of initiated thyroid cancer studies.
  • The market has seen significant M&A and strategic alliance activity during the past 22 months.
  • Ipsen/Exelixis, Ono Pharmaceutical, and Novartis are among the leading companies in the thyroid cancer therapeutics landscape.

Scope

What You Will Learn

  • Thyroid cancer therapeutics market dynamics and future outlook

  • Epidemiology trends and diagnosed prevalence analysis

  • Current treatment landscape and emerging therapeutic approaches

  • Targeted therapy and immunotherapy development trends

  • Pipeline assessment by phase, mechanism of action, and molecule type

  • Clinical trial activity, enrollment analysis, and geographic distribution

  • Pricing, reimbursement, and annual therapy cost insights

  • Phase transition success rates and likelihood of approval analysis

  • Competitive benchmarking of leading pharmaceutical companies

  • Mergers, acquisitions, and strategic alliance activity shaping the market

Target Buyers for This Report

This report may support decision-making for:

  • Pharmaceutical and biotech companies

  • Oncology drug developers

  • Healthcare investors and private equity firms

  • Licensing and business development teams

  • Competitive intelligence and market strategy professionals

  • Clinical development and pipeline strategy teams

  • Commercial and sales planning teams

  • Healthcare consultants and market analysts

  • Oncology-focused research organizations

  • Strategic partnership and M&A advisory teams

How Companies Use This Report

Pharmaceutical companies developing oncology therapies may use this report to assess pipeline competition, identify emerging treatment approaches, and evaluate future commercial opportunities within the thyroid cancer market.

Biotech firms and licensing teams may use the analysis to identify promising pipeline assets, benchmark clinical development strategies, and evaluate partnership or acquisition opportunities involving late-stage thyroid cancer therapies.

Investors and commercial strategy teams may also use the report to assess market competitiveness, forecast future treatment adoption trends, and evaluate the long-term growth potential of targeted therapies and immunotherapies.

In addition, clinical development teams may use the insights to benchmark trial activity, evaluate mechanism-of-action trends, and better understand evolving treatment pathways within thyroid cancer therapeutics.

Reasons to Buy

Benchmark Against Leading Thyroid Cancer Therapeutics Companies

The report helps benchmark pipeline strength, clinical trial activity, pricing strategies, treatment innovation, and competitive positioning across the thyroid cancer therapeutics landscape.

Moreover, it provides comparative insight into commercial strategies, late-stage pipeline assets, and market participation trends, helping organizations evaluate competitive threats and identify future market opportunities more effectively.

Built on Trusted GlobalData Pharma Intelligence

Built using GlobalData’s Pharma Intelligence Center, proprietary oncology datasets, epidemiology analysis, and market forecasting models, this report combines scientific, clinical, and commercial intelligence into a comprehensive strategic resource.

Trusted by pharmaceutical companies, biotech innovators, healthcare investors, and oncology strategy teams, and supported by expert analyst insight, the report provides a reliable view of the evolving thyroid cancer therapeutics market.

Act Now to Capture Opportunities in the Thyroid Cancer Therapeutics Market

As targeted therapies continue to transform thyroid cancer treatment and pipeline innovation accelerates across oncology research, the competitive landscape is expected to evolve significantly in the coming years.

Organizations that closely monitor clinical development activity, emerging therapeutic technologies, pricing dynamics, and strategic partnerships may be better positioned to strengthen market competitiveness, identify high-potential opportunities, and support long-term growth within the global thyroid cancer therapeutics industry.

Table of Contents

Table of Contents (PowerPoint Deck)

1 Preface

1.1 Contents

1.2 Report Scope

1.3 List of Tables and Figures

1.4 Abbreviations

2 Key Findings

3 Disease Landscape

3.1 Disease Overview

3.2 Epidemiology Overview

3.3 Treatment Overview

4 Marketed Drugs Assessment

4.1 Leading Marketed Drugs

4.2 Overview by Mechanism of Action

4.3 Overview by Molecule Type

4.4 Product Profile and Sales Forecast

5 Pricing and Reimbursement Assessment

6 Pipeline Drugs Assessment

6.1 Pipeline Drugs

6.2 Overview by Development Stage

6.3 Overview by Mechanism of Action

6.4 Overview by Molecule Type

6.5 Product Profile and Sales Forecast

6.6 Drug-specific PTSR and LoA

6.7 Indication-specific and Therapy Area-specific PTSR and LoA

7 Clinical Trials Assessment

7.1 Historical Overview

7.2 Overview by Phase

7.3 Overview by Status

7.4 Overview by Phase for Ongoing and Planned Trials

7.5 Trials with Virtual Components

7.6 Top 20 Biomarkers by Trial Phase

7.7 Overview of Trials by Geography

7.8 Single-Country and Multinational Trials by Region

7.9 Top 20 Sponsors with Breakdown by Phase

7.10 Top 20 Sponsors with Breakdown by Status

7.11 Overview by Endpoint Status

7.12 Overview by Race and Ethnicity

7.13 Enrollment Data

7.14 Top 20 countries for Trial Sites

7.15 Top 20 Sites Globally

7.16 Feasibility Analysis – Geographic Overview

7.17 Feasibility Analysis – Benchmark Models

8 Deals Landscape

8.1 Mergers, Acquisitions, and Strategic Alliances by Region

8.2 Recent Mergers, Acquisitions, and Strategic Alliances

9 Commercial Assessment

9.1 Key Market Players

10 Future Market Catalysts

11 Appendix

11.1 Methodology

11.2 Methodology – Sales Forecast

11.3 Methodology – Pricing and Reimbursement

11.4 Methodology – PTSR and LoA Analysis

11.5 About the Authors

11.6 Contact Us

11.7 Disclaimer

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape standard reports
Currency USD
$3,495

Can be used by individual purchaser only

Most Popular
$6,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$10,485

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Thyroid Cancer reports
Pharmaceuticals
New
Reflux Esophagitis (Gastroesophageal Reflux Disease): Market View, Current and Future…
$3,495 | June 2026
Pharmaceuticals
New
Hepatocellular Carcinoma (HCC): Epidemiology Report and Forecast to 2035
$9,995 | June 2026
Pharmaceuticals
New
Overweight and Obesity: Epidemiology Report and Forecast to 2035
$9,995 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape in real time.

  • Access a live Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more